FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2410493143> ?p ?o ?g. }

• W2410493143 endingPage "13" @default.
• W2410493143 startingPage "S2" @default.
• W2410493143 abstract "Despite advances in treatment, long-term outcome of patients with diffuse large B cell lymphoma (DLBCL) is no better today than reported in 1975. A recent study applying DNA microarray technology revealed that patients whose cancer related to patterns of genes expressed in germinal center lymphocytes responded more favorably to chemotherapy than patients whose cancer related to patterns of genes expressed in activated lymphocytes. cDNA and oligonucleotide microarrays are described, and their applications in cancer research are reviewed. In addition to DLBCL, microarray technology has been used to study several types of cancer. The applications of microarray technology are numerous and include profiling gene expression patterns in order to facilitate diagnosis and predict response to therapy; correlating patterns of gene expression with prognosis; and identifying genes and gene products that are associated with tumorigenic phenotype or with drug resistance, among other applications. Microarraytechnology has also been used in cell lines to correlate gene expression and chemotherapy response. Furthermore, microarray technology may provide a useful tool to examine the development of drug resistance in cancer and has recently been used to study changes in gene expression caused by activated c-Myc in primary human fibroblasts. Tissue microarrays are described. In addition to the amplification of limited tissue re sources, tissue microarrays have the advantages of limiting the variability associated with tissue processing and limiting the necessary amount of reagent. Tissue microarrays have been used to determine the frequencies of amplication of 3 major breast cancer genes and identify overexpression of ERBB2 mRNA; assess and compare gene amplification in benign prostatic hyperplasia, primary prostate carcinoma, recurrent prostate tumors, and metastatic tumors; compare aggressiveness of prostate carcinoma in 2 patient populations; and study gene amplification across various tumor types. Furthermore, DNA microarray and tissue microarray techniques can be combined to provide convergent evidence of findings and to examine different aspects of gene expression. DNA array technology may also be used to identify critical molecular targets or to identify the critical rate-limiting step in a cascade of genes under the influence of a mutated gene. The historical progression of goals of the National Cancer Institute is reviewed, as well as the economic impact of reduction in cancer-associated mortality. Future efforts should continue the investment in basic research and more effectively integrate it with clinical trials and with approaches to prevention and treatment." @default.
• W2410493143 created "2016-06-24" @default.
• W2410493143 creator A5038924006 @default.
• W2410493143 creator A5070243239 @default.
• W2410493143 date "2001-08-16" @default.
• W2410493143 modified "2023-10-18" @default.
• W2410493143 title "National Oncology Forum: perspectives for the year 2000." @default.
• W2410493143 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11504281" @default.
• W2410493143 hasPublicationYear "2001" @default.
• W2410493143 type Work @default.
• W2410493143 sameAs 2410493143 @default.
• W2410493143 citedByCount "4" @default.
• W2410493143 crossrefType "journal-article" @default.
• W2410493143 hasAuthorship W2410493143A5038924006 @default.
• W2410493143 hasAuthorship W2410493143A5070243239 @default.
• W2410493143 hasConcept C104317684 @default.
• W2410493143 hasConcept C114851261 @default.
• W2410493143 hasConcept C121608353 @default.
• W2410493143 hasConcept C150194340 @default.
• W2410493143 hasConcept C18431079 @default.
• W2410493143 hasConcept C186836561 @default.
• W2410493143 hasConcept C187882448 @default.
• W2410493143 hasConcept C193270364 @default.
• W2410493143 hasConcept C24361400 @default.
• W2410493143 hasConcept C502942594 @default.
• W2410493143 hasConcept C54355233 @default.
• W2410493143 hasConcept C60644358 @default.
• W2410493143 hasConcept C70721500 @default.
• W2410493143 hasConcept C8415881 @default.
• W2410493143 hasConcept C86803240 @default.
• W2410493143 hasConcept C95371953 @default.
• W2410493143 hasConceptScore W2410493143C104317684 @default.
• W2410493143 hasConceptScore W2410493143C114851261 @default.
• W2410493143 hasConceptScore W2410493143C121608353 @default.
• W2410493143 hasConceptScore W2410493143C150194340 @default.
• W2410493143 hasConceptScore W2410493143C18431079 @default.
• W2410493143 hasConceptScore W2410493143C186836561 @default.
• W2410493143 hasConceptScore W2410493143C187882448 @default.
• W2410493143 hasConceptScore W2410493143C193270364 @default.
• W2410493143 hasConceptScore W2410493143C24361400 @default.
• W2410493143 hasConceptScore W2410493143C502942594 @default.
• W2410493143 hasConceptScore W2410493143C54355233 @default.
• W2410493143 hasConceptScore W2410493143C60644358 @default.
• W2410493143 hasConceptScore W2410493143C70721500 @default.
• W2410493143 hasConceptScore W2410493143C8415881 @default.
• W2410493143 hasConceptScore W2410493143C86803240 @default.
• W2410493143 hasConceptScore W2410493143C95371953 @default.
• W2410493143 hasLocation W24104931431 @default.
• W2410493143 hasOpenAccess W2410493143 @default.
• W2410493143 hasPrimaryLocation W24104931431 @default.
• W2410493143 hasRelatedWork W1531528770 @default.
• W2410493143 hasRelatedWork W1974599192 @default.
• W2410493143 hasRelatedWork W2365629105 @default.
• W2410493143 hasRelatedWork W2374855950 @default.
• W2410493143 hasRelatedWork W2383598698 @default.
• W2410493143 hasRelatedWork W2384466963 @default.
• W2410493143 hasRelatedWork W2394082563 @default.
• W2410493143 hasRelatedWork W262379139 @default.
• W2410493143 hasRelatedWork W2900947575 @default.
• W2410493143 hasRelatedWork W74695042 @default.
• W2410493143 hasVolume "7 Suppl 1" @default.
• W2410493143 isParatext "false" @default.
• W2410493143 isRetracted "false" @default.
• W2410493143 magId "2410493143" @default.
• W2410493143 workType "article" @default.